Skip to main content

Weight loss biotech plans IPO as demand builds for anti-obesity treatments

Aardvark Therapeutics’ drug has been shown in trials to suppress cravings in patients with rare genetic form of obesity

https://ift.tt/IETGnPZ

Comments

Popular posts from this blog